sdz pco 400 has been researched along with n(6)-cyclopentyladenosine in 1 studies
| Studies (sdz pco 400) | Trials (sdz pco 400) | Recent Studies (post-2010) (sdz pco 400) | Studies (n(6)-cyclopentyladenosine) | Trials (n(6)-cyclopentyladenosine) | Recent Studies (post-2010) (n(6)-cyclopentyladenosine) |
|---|---|---|---|---|---|
| 24 | 0 | 3 | 605 | 0 | 62 |
| Protein | Taxonomy | sdz pco 400 (IC50) | n(6)-cyclopentyladenosine (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.2256 | |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 1.16 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0027 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 1.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carruthers, AM; Fozard, JR | 1 |
1 other study(ies) available for sdz pco 400 and n(6)-cyclopentyladenosine
| Article | Year |
|---|---|
The cardiovascular effects of selective adenosine A1 and A2 receptor agonists in the pithed rat: no role for glibenclamide-sensitive potassium channels.
Topics: Adenosine; Adrenergic alpha-Agonists; Angiotensin II; Animals; Benzopyrans; Blood Pressure; Cardiovascular System; Cyclopentanes; Glyburide; Heart Rate; Male; Parasympatholytics; Phenethylamines; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Sensitivity and Specificity; Theophylline; Time Factors | 1993 |